{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:03:29Z","timestamp":1784527409029,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The coexistence of stiff person syndrome (SPS) and myasthenia gravis (MG) is exceptionally rare, with fewer than 20 cases reported to date. Thymoma has been identified in a substantial proportion of these patients, suggesting a potential shared autoimmune mechanism. We report a 43-year-old woman who initially presented with progressive limb stiffness, painful muscle spasms, and gait impairment. She was diagnosed with SPS based on positive anti-glutamic acid decarboxylase (GAD) antibodies and characteristic electromyographic findings. Her symptoms improved after immunotherapy but relapsed following corticosteroid withdrawal. Four years later, she developed fluctuating limb weakness and ptosis and was subsequently diagnosed with anti-acetylcholine receptor antibody-positive MG associated with type B2 thymoma. Following thymectomy and postoperative radiotherapy, COVID-19 infection precipitated a myasthenic crisis requiring intensive care support. Conventional treatments, including plasma exchange, intravenous immunoglobulin, corticosteroids, and rituximab, failed to achieve satisfactory clinical improvement. In contrast, treatment with efgartigimod resulted in marked recovery of respiratory and motor function. During follow-up through December 2025, no recurrence of SPS symptoms or MG exacerbation was observed. This case highlights the complex association among SPS, MG, and thymoma and supports the possibility that thymoma may contribute to the development of multiple autoimmune neurological disorders. Furthermore, efgartigimod may represent a promising therapeutic option for refractory thymoma-associated MG in patients with overlapping SPS and MG. Long-term surveillance for thymoma and additional autoimmune manifestations should be considered in patients with SPS.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1825974","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:33:57Z","timestamp":1784525637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingjing","family":"Nie","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"]},{"name":"Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"]},{"name":"Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, The Second Xiangya Hospital, Central South University","place":["Changsha, Hunan, China"]},{"name":"The \u201cDouble-First Class\u201d Application Characteristic Discipline of Hunan Province, Clinical Medicine, Changsha Medical University","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00415-025-13103-2","article-title":"Core diagnostic features of stiff person syndrome: insights from a case-control study","volume":"272","author":"Roy","year":"2025","journal-title":"J Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.14328","article-title":"Neurophysiological insights into the pathophysiology of stiff-person spectrum disorders","volume":"12","author":"Moura","year":"2025","journal-title":"Mov Disord Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.aace.2024.07.003","article-title":"Stiff person syndrome and brittle type 1 diabetes: report of 2 cases","volume":"10","author":"Quintal-Medina","year":"2024","journal-title":"AACE Clin Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1360222","article-title":"Stiff-person syndrome in association with Hashimoto's thyroiditis: a case report","volume":"15","author":"Chen","year":"2024","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2017-0081","article-title":"Paraneoplastic movement disorders","volume":"29","author":"Poplawska-Domaszewicz","year":"2018","journal-title":"Rev Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563700","article-title":"Progressive encephalomyelitis with rigidity and myoclonus after thymectomy in a woman with myasthenia gravis","volume":"16","author":"Qin","year":"2025","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.70149","article-title":"A case of myasthenia gravis and stiff-person syndrome that improved after extended thymectomy","volume":"13","author":"Okado","year":"2025","journal-title":"Respirol Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50017","article-title":"Myasthenia gravis: a systematic review","volume":"15","author":"Mishra","year":"2023","journal-title":"Cureus"},{"key":"B9","volume-title":"Thymectomy","author":"Bennett","year":"2025"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-014-0484-9","article-title":"New onset of myasthenia gravis 10 years after proton beam therapy for thymoma","volume":"64","author":"Karasaki","year":"2016","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51492","article-title":"Drug-refractory myasthenia gravis: clinical characteristics, treatments, and outcome","volume":"9","author":"Cortes-Vicente","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"B12","article-title":"Clinical characteristics of refractory myasthenia gravis patients","volume":"86","author":"Suh","year":"2013","journal-title":"Yale J Biol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20210312-00618","article-title":"To attach great importance to the identification of refractory myasthenia gravis","volume":"101","author":"Liu","year":"2021","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B14","first-page":"98","article-title":"Stiff person syndrome and myasthenia gravis","volume":"50","author":"Saravanan","year":"2002","journal-title":"Neurol India"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309201","article-title":"Stiff-person syndrome: insights into a complex autoimmune disorder","volume":"86","author":"Baizabal-Carvallo","year":"2015","journal-title":"J Neurology Neurosurgery Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-59680-8_105","article-title":"Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody","volume":"63","author":"Zhou","year":"2021","journal-title":"Muscle Nerve"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/bf02335562","article-title":"Autoimmune myastenia gravis with thymoma following the spontaneous remission of stiff-man syndrome","volume":"11","author":"Piccolo","year":"1990","journal-title":"Ital J Neurol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.36.308","article-title":"Stiff-man syndrome associated with antecedent myasthenia gravis and organ-specific autoimmunopathy","volume":"36","author":"Aso","year":"1997","journal-title":"Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bjacepd\/2.3.88","article-title":"Stiff-persons' syndrome associated with thymoma and subsequent myasthenia gravis","volume":"20","author":"Nicholas","year":"1997","journal-title":"Muscle Nerve"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.036558","article-title":"Stiff person syndrome with eye movement abnormality, myasthenia gravis, and thymoma","volume":"76","author":"Thomas","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2014.0666","article-title":"PET-positive extralimbic presentation of anti-glutamic acid decarboxylase antibody-associated encephalitis","volume":"16","author":"Kojima","year":"2014","journal-title":"Epileptic Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/neuroIndia.ni_493_16","article-title":"Stiff-person syndrome after thymectomy in myasthenia gravis mimicking a post-thymectomy myasthenic crisis","volume":"65","author":"Lee","year":"2017","journal-title":"Neurol India"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7979","article-title":"Thymoma-associated progressive encephalomyelitis with rigidity and myoclonus (PERM) with myasthenia gravis","volume":"56","author":"Morise","year":"2017","journal-title":"Intern Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51181","article-title":"The case of a 30-year-old man with subacute gait instability, weakness, and muscle spasms","volume":"7","author":"Mehta","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5761\/atcs.cr.21-00052","article-title":"Thymoma-related stiff-person syndrome with successfully treated by surgery","volume":"28","author":"Sasaki","year":"2022","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11970-1","article-title":"Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome","volume":"271","author":"Di Stefano","year":"2024","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000539186","article-title":"Severe relapsing autoimmune encephalitis with GABA(A) receptor, titin, and AchR antibodies in a patient with thymoma: a case report","volume":"16","author":"Boisclair","year":"2024","journal-title":"Case Rep Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17519","article-title":"First reported case of thymoma-associated multiorgan autoimmunity induced by COVID-19","volume":"51","author":"Hyobu","year":"2024","journal-title":"J Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9834","article-title":"Outcomes of COVID-19 infection and vaccination among individuals with myasthenia gravis","volume":"6","author":"Alcantara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12111221","article-title":"The impact of COVID-19 vaccination and infection on the exacerbation of myasthenia gravis","volume":"12","author":"Jiang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01747-6","article-title":"(Limbic encephalitis and subclinical Hashimoto's disease associated with anti-GAD and anti-titin antibodies in a case of prostate cancer)","volume":"122","author":"Karsidag","year":"2022","journal-title":"Acta Neurol Belg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07460-5","article-title":"Efgartigimod as a novel FcRn inhibitor for autoimmune disease","volume":"45","author":"Yang","year":"2024","journal-title":"Neurol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1510992","article-title":"A real-world pharmacovigilance study of efgartigimod alfa in the FDA adverse event reporting system database","volume":"16","author":"Yang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2025.2497840","article-title":"Safety profile of efgartigimod from global clinical trials across multiple immunoglobulin G-mediated autoimmune diseases","volume":"21","author":"Gwathmey","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-385157-4.00646-1","article-title":"Stiff person syndrome and GAD antibody-spectrum disorders","volume":"30","author":"Dalakas","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1471115","article-title":"The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00415-025-13226-6","article-title":"Clonidine for the management of crises in stiff-person syndrome","volume":"272","author":"Lima","year":"2025","journal-title":"J Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1825974\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:34:03Z","timestamp":1784525643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1825974\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1825974"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1825974","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1825974"}}